Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7411 p123-128
29 July 2006

This section
Reprint   Photocopy

PDF 150K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events

Pages: 123   124   125   126   127   128 

123 Briefing paper highlights pharmacy's role to PM Ways in which the pharmacy profession is helping to improve Britain's health and how the profession might evolve to complement the Government's public health agenda are discussed in a briefing paper that was distributed to delegates at an “Our nation's future” lecture delivered by Prime Minister Tony Blair in Nottingham this week
PJ 2006;277:123
Full Text

123 Boots plans to house outpatient services for primary care trusts Some NHS health care services that would normally be offered in hospital outpatient clinics may soon be available in a Boots pharmacy
PJ 2006;277:123
Full Text


124 Pharmacists need to advise public about allergies Pharmacists can play a crucial role in providing the public with high-quality information about allergies, a Department of Health review of allergy services has concluded
PJ 2006;277:124
Full Text

124 Regulators and manufacturers should work more closely together Regulators and drug developers need to communicate more closely with one another, and UK schools of medical sciences, including pharmacy, should consider organising secondments to commercial clinical trial organisations, the expert scientific group established to examine clinical trials has concluded
PJ 2006;277:124
Full Text

124 No compelling evidence for herbal medicine use in COPD There is no compelling evidence to support the use of herbal medicine for treating chronic obstructive pulmonary disease (COPD), according to a systematic review
PJ 2006;277:124
Full Text

124 “Ever smoked” campaign Developing Patient Partnerships has launched a campaign called “Ever smoked” to raise awareness of chronic obstructive pulmonary disease following research commissioned by the health education charity that revealed most people have not heard of the condition
PJ 2006;277:124
Full Text


125 Indicative rates for enhanced services set in Wales Community Pharmacy Wales and local health boards in Wales have developed “indicative rates” for the provision of three national enhanced services, it was announced last week. Concerns had previously been raised that establishing benchmark prices for enhanced services could contravene the Competition Act
PJ 2006;277:125
Full Text

125 Transitional arrangements for home oxygen service come to an end but FP10s continue Transitional arrangements for the supply of home oxygen in England and Wales are due to come to an end next week, but pharmacies will continue to be reimbursed for prescriptions for home oxygen until next year, NHS Primary Care Contracting announced last week
PJ 2006;277:125
Full Text

125 AIMp widens membership Members of the Association of Independent Multiple Pharmacies (AIMp) have approved changes to the criteria for membership
PJ 2006;277:125
Full Text

125 Welsh prescription charge From 1 August, the Welsh prescription charge of £3 will only apply automatically to prescriptions on Welsh forms dispensed in pharmacies in Wales
PJ 2006;277:125
Full Text

125 Welsh smoking ban Consultation began last week on the ban on smoking in enclosed public places in Wales
PJ 2006;277:125
Full Text

125 Health Bill becomes Act The Health Bill received Royal Assent on 19 July and so becomes the Health Act 2006
PJ 2006;277:125
Full Text

125 PSNC members An amendment to the Pharmaceutical Services Negotiating Committee constitution will enable members to be co-opted, rather than elected, if no regional representative is found in the regional election process
PJ 2006;277:125
Full Text


126 More work needed to combat C difficile infections Although the incidence of methicillin-resistant Staphylococcus aureus infections in hospitals is falling, more work is needed to combat other health care associated infections, such as Clostridium difficile, the Health Protection Agency said this week
PJ 2006;277:126
Full Text

126 Study authors discourage immediate use of chloramphenicol Delaying the prescribing of antibiotics for the treatment of conjunctivitis is a more favourable strategy than immediate treatment with chloramphenicol drops, according to the authors of a recent study
PJ 2006;277:126
Full Text

126 Purulent rhinitis will get better without antibiotics Antibiotics for treatment of acute purulent rhinitis, although likely to be effective, should not be used first line, conclude researchers
PJ 2006;277:126
Full Text

126 “Who regulates health and social care” leaflet launched A leaflet identifying the regulatory body responsible for each health and social care profession and explaining what regulation means is available via the Royal Pharmaceutical Society's website
PJ 2006;277:126
Full Text


127 Over 11,000 scripts written by pharmacists in 2005 Over 11,000 prescriptions were written by pharmacist supplementary prescribers in England in 2005, statistics issued by the Department of Health last week reveal
PJ 2006;277:127
Full Text

127 PPRS saves NHS £1.3bn over five years Medicine price cuts of 4.5 per cent agreed in October 1999 had saved the NHS £1.3bn by the end of 2004, the Department of Health's ninth report on the Pharmaceutical Price Regulation Scheme reveals
PJ 2006;277:127
Full Text

127 Yorkshire and Humber PCTs target medicines wastage A new campaign to raise awareness about medicines wastage is advising people to discuss their medicines with a pharmacist or GP on a regular basis
PJ 2006;277:127
Full Text

127 HIV drug regimen better with efavirenz than nelfinavir Efavirenz is better than nelfinavir for treating HIV when part of a triple drug regimen using didanosine and stavudine as the initial nucleoside analogue reverse transcriptase inhibitor (NRTI) backbone, according to data published
PJ 2006;277:127
Full Text


128 NICE accepts two drugs for severe plaque psoriasis Etanercept (Enbrel) and efalizumab (Raptiva) have been recommended for the treatment of severe plaque psoriasis by the National Institute for Health and Clinical Excellence
PJ 2006;277:128
Full Text

128 NICE publishes guidance for the management of bipolar disorder This week a new guideline for the management of people with bipolar disorder has been issued by the National Institute for Health and Clinical Excellence and the National Collaborating Centre for Mental Health
PJ 2006;277:128
Full Text

128 Imatinib and doxorubicin implicated in cardiac toxicities Two drugs — imatinib and doxorubicin — have been implicated in the development of cardiac toxicities in studies published this month
PJ 2006;277:128
Full Text

128 Do not mask inappropriate variations in care, says CMO Professional autonomy must not be used to mask inappropriate variations in the way evidence is applied to health care, Sir Liam Donaldson, England's chief medical officer, says in his annual report published last week
PJ 2006;277:128
Full Text

Back to Top


©The Pharmaceutical Journal